<i>BRAF</i> Mutation in Colorectal Cancers: From Prognostic Marker to Targetable Mutation
The Raf murine sarcoma viral oncogene homolog B (<i>BRAF</i>) mutation is detected in 8–12% of metastatic colorectal cancers (mCRCs) and is strongly correlated with poor prognosis. The recent success of the BEACON CRC study and the development of targeted therapy have led to the determin...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2020-11-01
|
| Series: | Cancers |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2072-6694/12/11/3236 |